Dexcom (DXCM) Cost of Revenue (2010 - 2026)
Dexcom (DXCM) posted quarterly Cost of Revenue of $478.4 million for Q2 2026, up 2.16% year-over-year from $468.3 million in Q2 2025, and up 8.33% quarter-over-quarter from $441.6 million in Q1 2026.
Dexcom (DXCM) Cost of Revenue (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Cost of Revenue for 17 consecutive years, with $478.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cost of Revenue rose 2.16% year-over-year to $478.4 million; the TTM figure through Jun 2026 stood at $1.9 billion (up 5.15% YoY), while the FY2025 annual figure was $1.9 billion, up 16.64% from the prior year.
- Cost of Revenue rose to $478.4 million in Q2 2026 per DXCM's latest filing, from $441.6 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $478.4 million in Q2 2026 and bottomed at $230.7 million in Q1 2022.
- Historically, Cost of Revenue has averaged $374.2 million across 5 years, with a median of $377.8 million in 2023.
- Annual changes were most pronounced in 2022 — Cost of Revenue surged 43.2% — and 2026, when it declined 1.21%.
- Dexcom's Cost of Revenue stood at $273.9 million in 2022, then jumped by 37.97% to $377.9 million in 2023, then increased by 21.12% to $457.7 million in 2024, then increased by 2.01% to $466.9 million in 2025, then advanced by 2.46% to $478.4 million in 2026.
- Business Quant data shows DXCM's Cost of Revenue at $478.4 million in Q2 2026, $441.6 million in Q1 2026, and $466.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.40 Bn | 18.99 Bn | 1.54 Bn | 635.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 478.40 Mn |
| Jun 30, 2026 | 478.40 Mn |
| Mar 31, 2026 | 441.60 Mn |
| Mar 31, 2026 | 441.60 Mn |
| Dec 31, 2025 | 466.90 Mn |
| Dec 31, 2025 | 466.90 Mn |
| Sep 30, 2025 | 477.90 Mn |
| Sep 30, 2025 | 477.90 Mn |
| Jun 30, 2025 | 468.30 Mn |
| Jun 30, 2025 | 468.30 Mn |
| Mar 31, 2025 | 447.00 Mn |
| Mar 31, 2025 | 447.00 Mn |
| Dec 31, 2024 | 457.70 Mn |
| Dec 31, 2024 | 457.70 Mn |
| Sep 30, 2024 | 400.40 Mn |
| Sep 30, 2024 | 400.40 Mn |
| Jun 30, 2024 | 377.60 Mn |
| Jun 30, 2024 | 377.60 Mn |
| Mar 31, 2024 | 359.10 Mn |
| Mar 31, 2024 | 359.10 Mn |